subscribeSubscribe
Gilead, US square off in billion-dollar HIV drug patent trial

Gilead, US square off in billion-dollar HIV drug patent trial
Blake Brittain REUTERS
03 May 2023
Share Share
Gilead caused injuries while waiting to develop safer HIV drugs,lawsuit claims

Gilead caused injuries while waiting to develop safer HIV drugs,lawsuit claims
FIERCE PHARMA
07 Apr 2023
Share Share
Hagens Berman Sobol , Hilliard Announce a Class Action Antiretroviral Drugs

Hagens Berman Sobol , Hilliard Announce a Class Action Antiretroviral Drugs
PR NEWSWIRE
28 Dec 2022
Share Share
Federal claims court rules in favor of Gilead in CDC Truvada patent case

Federal claims court rules in favor of Gilead in CDC Truvada patent case
Nicole DeFeudis ENDPTS
01 Dec 2022
Share Share
Lupin gets USFDA nod for HIV drug under PEPFAR

Lupin gets USFDA nod for HIV drug under PEPFAR
ECONOMIC TIMES
30 Jun 2021
Share Share
Study shows newer anti-HIV drugs safest, most effective during pregnancy

Study shows newer anti-HIV drugs safest, most effective during pregnancy
PHARMABIZ
12 Mar 2020
Share Share
Gilead`s Descovy not worth the higher price

Gilead`s Descovy not worth the higher price
Eric Sagonowsky FIERCE PHARMA
10 Mar 2020
Share Share
FDA Confirms Paragraph IV Patent Challenge of Descovy 208215 (Emtricitabine and Tenofovir Alafenamide Fumarate) Tablets

FDA Confirms Paragraph IV Patent Challenge of Descovy 208215 (Emtricitabine and Tenofovir Alafenamide Fumarate) Tablets
FDA
07 Jan 2020
Share Share
Gilead, seeking HIV patent extension, faces `gamesmanship` claims from patients

Gilead, seeking HIV patent extension, faces `gamesmanship` claims from patients
 Eric Sagonowsky  FIERCE PHARMA
07 Dec 2019
Share Share
Gilead’s converting Truvada PrEP users to Descovy faster than expected

Gilead’s converting Truvada PrEP users to Descovy faster than expected
Angus Liu  FIERCE PHARMA
03 Dec 2019
Share Share